Insider Transactions last 24 months for Aardvark Therapeutics, Inc.  -  NSDQ: AARD

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Lee Tien-LiChief Executive Officer12/11/2025APDirectCOM7,000$14.49$101,395.001,551,613
Sun NelsonChief Financial Officer12/11/2025APDirectCOM3,000$14.40$43,200.00108,484
Jones BryanChief Operating Officer10/15/2025AMDirectCOM1,250$4.24$5,300.001,250
Lee Tien-LiChief Executive Officer10/15/2025AMDirectCOM1,229$4.24$5,210.961,544,613
Lee Tien-LiChief Executive Officer09/15/2025APDirectCOM3,500$9.94$34,804.701,543,384
Lee Tien-LiChief Executive Officer09/15/2025APDirectCOM6,500$9.51$61,818.901,539,884
Lee Tien-LiChief Executive Officer09/12/2025APDirectCOM5,000$8.50$42,515.501,533,384
Lee Tien-LiChief Executive Officer09/11/2025APDirectCOM6,000$7.82$46,926.001,528,384
Lee Tien-LiChief Executive Officer09/10/2025APDirectCOM9,000$7.91$71,212.501,522,384
Sun NelsonChief Financial Officer09/09/2025APDirectCOM6,000$8.07$48,439.80105,484
Lee Tien-LiChief Executive Officer08/28/2025AMDirectCOM17,209$4.24$72,966.161,513,384
Cormorant Asset Management, LpOther02/14/2025APIndirectCOM187,500$16.00$3,000,000.00987,689
Cormorant Asset Management, LpOther02/14/2025ACIndirectCOM800,189$0.00$0.00800,189
Sun NelsonChief Financial Officer02/14/2025APDirectCOM10,000$16.00$160,000.0099,484
Sun NelsonChief Financial Officer02/14/2025ACDirectCOM7,001$0.00$0.0089,484
Lee Tien-LiChief Executive Officer02/14/2025APDirectCOM16,542$16.00$264,672.001,496,175
Lee Tien-LiChief Executive Officer02/14/2025ACDirectCOM41,303$0.00$0.001,479,633
Vickers Venture Fund Vi Pte LtdOther02/14/2025ACIndirectCOM413,491$0.00$0.002,050,902
Vickers Venture Fund Vi Pte LtdOther02/14/2025ACIndirectCOM1,637,411$0.00$0.001,637,411
Chi JeffreyDirector02/14/2025ACIndirectCOM133,364$0.00$0.00133,364
Decheng Capital Global Life Sciences Fund Iv, L.P.Other02/14/2025APIndirectCOM625,000$16.00$10,000,000.00958,412
Decheng Capital Global Life Sciences Fund Iv, L.P.Other02/14/2025APIndirectCOM625,000$16.00$10,000,000.002,958,887
Decheng Capital Global Life Sciences Fund Iv, L.P.Other02/14/2025ACIndirectCOM333,412$0.00$0.00333,412
Decheng Capital Global Life Sciences Fund Iv, L.P.Other02/14/2025ACIndirectCOM2,333,887$0.00$0.002,333,887
1   You are at page 1 of 1 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel